Increasing Colorectal and Breast Cancer Screnning in Women

增加女性结直肠癌和乳腺癌筛查

基本信息

项目摘要

DESCRIPTION (provided by applicant): Appropriate cancer screening in women 50 and older reduces both colorectal cancer (CRC) and breast cancer (BC) mortality, but adherence to both screening behaviors is inadequate. The purpose of this proposal is to test a tailored and interactive intervention to increase both CRC and BC screening in women 51 to 75 who are non-adherent to CRC but adherent to BC (Group A) or to a group which is non-adherent to both CRC and BC (Group B) screening. The intervention is based on theoretical modeling that will simultaneously address more than one health behavior. We will compare a tailored interactive program delivered via a mailed digital video disc (TIDVD), a cancer screening call (CSC), the combination of a TIDVD + CSC, and usual care to increase CRC and BC screening during a single point of contact. Approximately 2616 women, who are members of a family care practice network and insured by Wellpoint will be assessed for eligibility. Eligible women will be either non-adherent to CRC only (Group A) or non-adherent to both CRC and BC (Group B) screening. After eligibility assessment and consent, women will be enrolled in the study and randomly assigned to the TIDVD, CSC, TIDVD + CSC, or usual care. The TIDVD program and CSC will tailor messages to recipients' perceptions of risk, benefits, barriers, and self-efficacy associated with either CRC or with CRC and BC. Interventions will encourage either CRC screening building on their success with BC screening (Group A) or will encourage both screenings simultaneously (Group B) if the woman is non-adherent to either screening. Women in interventions groups will have the ability to schedule BC or CRC screening via telephone without a clinic visit. All intervention arms can be delivered directly to the women in their homes. One week after baseline telephone assessment, interventions will be delivered. Outcomes will be obtained by telephone interviews as well as through claims data and medical records audit at 6 months. Process data about the intervention will be collected at 4 weeks post intervention. Cost effectiveness will be computed for both interventions to speed translation to practice if either or both are found to be efficacious. PUBLIC HEALTH RELEVANCE: Detecting breast and colorectal cancer early through routine screening could dramatically reduce death from these cancers. This research will test a program that includes both breast and colorectal cancer screening interventions delivered through a DVD that is mailed directly to a woman's home, a cancer screening call, and a combination of the two strategies to increase breast and colorectal cancer. Women can schedule screening while on the phone. If found effective, these interventions could be easily incorporated into the health care system.
描述(由申请人提供):50岁及以上女性的适当癌症筛查可降低结直肠癌(CRC)和乳腺癌(BC)的死亡率,但对这两种筛查行为的坚持是不够的。本提案的目的是测试一种定制的互动干预措施,以增加51至75岁未遵守CRC但遵守BC(A组)或不遵守CRC和BC(B组)筛查的妇女的CRC和BC筛查。该干预措施基于理论建模,将同时解决多种健康行为。我们将比较通过邮寄数字视频光盘(TIDVD)、癌症筛查电话(CSC)、TIDVD + CSC的组合以及常规护理提供的定制互动程序,以在单点接触期间增加CRC和BC筛查。将对大约2 616名妇女进行资格评估,她们是家庭护理实践网络的成员,由Wellpoint保险。合格的女性将是仅不依从CRC(A组)或不依从CRC和BC(B组)筛选的女性。在合格性评估和知情同意后,女性将入组研究,并随机分配至TIDVD、CSC、TIDVD + CSC或常规治疗组。TIDVD计划和CSC将根据接受者对与CRC或CRC和BC相关的风险、益处、障碍和自我效能的看法定制信息。干预措施将鼓励在BC筛查成功的基础上进行CRC筛查(A组),或者如果女性不遵守任何一种筛查,则鼓励同时进行两种筛查(B组)。干预组的妇女将能够通过电话安排BC或CRC筛查,而无需诊所访视。所有干预武器都可以直接送到妇女家中。基线电话评估后一周,将提供干预措施。将通过电话访谈以及6个月时的索赔数据和医疗记录审计获得结果。将在干预后4周收集有关干预的过程数据。将计算两种干预措施的成本效益,以加快转化为实践,如果发现其中一种或两种干预措施都有效。 公共卫生相关性:通过常规筛查早期发现乳腺癌和结直肠癌可以大大降低这些癌症的死亡率。这项研究将测试一项计划,该计划包括通过直接邮寄到女性家中的DVD提供的乳腺癌和结直肠癌筛查干预措施,癌症筛查电话以及两种策略的组合,以增加乳腺癌和结直肠癌。女性可以在打电话的时候安排筛查。如果发现有效,这些干预措施可以很容易地纳入卫生保健系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victoria Lee Champion其他文献

Variables Related to Breast Self-Examination: Model Generation
与乳房自检相关的变量:模型生成
  • DOI:
    10.1111/j.1471-6402.1992.tb00241.x
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Victoria Lee Champion;T. K. Miller
  • 通讯作者:
    T. K. Miller

Victoria Lee Champion的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victoria Lee Champion', 18)}}的其他基金

Implementing evidence based colorectal cancer screening in rural clinics
在农村诊所实施循证结直肠癌筛查
  • 批准号:
    10567653
  • 财政年份:
    2023
  • 资助金额:
    $ 62.37万
  • 项目类别:
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
改善农村妇女筛查干预措施的比较有效性
  • 批准号:
    9310329
  • 财政年份:
    2015
  • 资助金额:
    $ 62.37万
  • 项目类别:
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
改善农村妇女筛查干预措施的比较有效性
  • 批准号:
    8987262
  • 财政年份:
    2015
  • 资助金额:
    $ 62.37万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    9067236
  • 财政年份:
    2014
  • 资助金额:
    $ 62.37万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    8700057
  • 财政年份:
    2014
  • 资助金额:
    $ 62.37万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    8841693
  • 财政年份:
    2014
  • 资助金额:
    $ 62.37万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    7890201
  • 财政年份:
    2010
  • 资助金额:
    $ 62.37万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    8470132
  • 财政年份:
    2010
  • 资助金额:
    $ 62.37万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    8270610
  • 财政年份:
    2010
  • 资助金额:
    $ 62.37万
  • 项目类别:
Technology-Enhanced Quitline Services to Prevent Smoking Relapse
技术增强的戒烟热线服务可防止复吸
  • 批准号:
    8433250
  • 财政年份:
    2009
  • 资助金额:
    $ 62.37万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了